If you're looking to boost your income portfolio this week, then you may want to look at the shares listed below.
Here's why these ASX dividend shares have been tipped as buys:
Dexus Industria REIT (ASX: DXI)
The first ASX dividend share that could be in the buy zone is Dexus Industria.
It is an industrial and office focused property company that was formerly known as APN Industria. Dexus Industria owns interests in office and industrial properties across the country that provide functional and affordable workspaces for businesses.
Morgans is a fan of the company. It recently commented:
DXI's key industrial markets remain robust with the outlook for solid rental growth backed by strong tenant demand. The development pipeline also provides near and medium term upside potential. A key focus will be the leasing up of the business park assets and a potential divestment could be a positive catalyst. While the portfolio remains well positioned we acknowledge there will be near-term uncertainty around interest rates.
Its analysts currently have an add rating and $3.25 price target on the company's shares.
They are also forecasting attractive dividends per share of 17.3 cents in FY 2023 and 16.4 cents in FY 2024. Based on the current Dexus Industria share price of $2.70, this will mean yields of 6.4% and 6.1%, respectively.
Healthco Healthcare and Wellness REIT (ASX: HCW)
Another ASX dividend share that has been named as a buy is the Healthco Healthcare and Wellness REIT.
It is a real estate investment trust with a focus on hospitals, aged care, childcare, life sciences, and primary care properties.
Goldman Sachs is very positive on the company and recently named it as one of its top picks in the sector. The broker commented:
[T]he REIT remains one of our top picks in the sector given 1) its net cash position with over $450mn of liquidity, providing flexibility for near term opportunities, 2) its diversified mix of strong tenant covenants in sub-sectors that are majority government-backed across the care spectrum, mitigating potential tenant credit risks, 3) Healthcare and childcare assets valuations have remained resilient, 4) the expansive forecast future demand for assets across the care spectrum, underpinning development opportunities, and 5) inexpensive valuation.
Its analysts have a conviction buy rating and $2.14 price target on its shares.
In respect to dividends, Goldman expects dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.65 this will mean yields of 4.5% for investors.
